GSK plc GSK announced that the FDA has granted Orphan Drug Designation to GSK’227, its investigational B7-H3-targeted ...

Dr. Charles M. Rudin highlighted new small cell lung cancer therapies, including T cell engagers, antibody-drug conjugates, as well as emerging cell, radiotherapy and combination approaches, during an ...

Small cell lung cancer (SCLC) is a fast-growing cancer that develops in cells within the lung. A range of medical tests and procedures are available to help doctors diagnose SCLC and create an ...

Dr. Charles M. Rudin discussed recent treatment advancements for patients with small cell lung cancer.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the publication of one ...

Small cell lung cancer (SCLC) may increase the risk of pneumonia due to a weakened immune system or structural changes to the lungs. SCLC is one of the two main types of lung cancer. Pneumonia is an ...

Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a common complication of small cell lung cancer (SCLC). It can cause many symptoms related to low sodium or other electrolyte ...

Nine small health issues that could be an early sign of lung cancer - As the NHS offers a ‘revolutionary’ blood test, here ...

Key milestone achieved as Company advances clinical program to full approval trial of ateganosine sequenced with a checkpoint ...

Early-stage non-small cell lung cancer (NSCLC) offers a better prognosis than advanced stages. Staging helps inform treatment by describing your cancer's size, lymph node involvement, and metastasis.

Medicaid expansion is associated with lower 2- and 4-year mortality among patients with resectable non-small cell lung cancer ...

Ask a clinical question and tap into Healio AI's knowledge base. Lung cancer is generally the top cause of cancer-related death globally and in the United States (US). In the US in 2023, lung cancer ...